India’s Drug Regulatory Apparatus Set For ‘Big Ticket’ Changes
Also Looks Inward To Improve
India’s drugs regulator sets out plans for extensive digitization across the regulatory value chain and regulatory rationalization initiatives, while also “looking inward” to up its game as it tightens processes and enforcement. Audit action under the revised GMP norms is also being kicked off.
